HSTMNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

HEALTHSTREAM INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$33.31+0.18 (+0.54%)

Close on Oct 19, 2026

Market cap: $976.45M
P/E (TTM): 46.3
Dividend yield: 0.37%

HEALTHSTREAM INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	304	292	279	267	257	245	254	232	215	192	209	171	132	104	82	66	57
Cost of Revenue	107	98	95	91	91	89	104	96	87	–	–	–	–	42	31	24	21
Gross Profit	197	194	184	176	166	155	150	136	128	–	–	–	–	62	51	42	36
Research & Development	51	49	46	44	42	32	29	26	24	24	24	16	12	8.61	7.47	6.99	6.29
Selling, General & Admin	–	–	–	–	–	–	–	–	–	–	–	53	42	33	27	23	20
Selling & Marketing	49	47	46	44	39	35	38	36	39	35	36	30	24	20	16	13	11
General & Administrative	–	–	–	–	–	–	–	–	–	–	–	23	18	13	11	9.58	8.58
Advertising Expenses	–	–	–	–	–	–	–	–	1.00	1.00	1.10	0.70	0.40	0.35	0.25	0.13	–
Total Costs & Expenses	284	270	263	254	249	229	239	216	205	185	195	154	118	90	71	59	52
Operating Income	20	21	16	12	8.06	16	15	15	9.41	7.17	14	16	15	13	11	7.06	5.12
Income from Equity Investments	-0.19	-0.23	-0.38	-0.75	-0.46	-0.05	0.06	0.04	-0.01	0.12	-0.12	-0.07	-0.04	-0.02	–	–	–
Other Non-Operating Income	-0.36	-0.32	0.14	2.69	-0.29	2.01	3.21	1.08	0.73	0.58	0.16	0.15	0.18	0.12	0.01	-0.02	-0.02
Asset Impairment Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	–
Gain (Loss) on Sale of Assets	–	0	0	0.03	-0.02	0	0	–	-0.10	–	0.07	–	–	–	–	–	–
Pretax Income	23	25	19	16	7.77	18	18	17	10	7.75	14	17	15	14	11	7.04	5.11
Income Tax Expense	4.88	4.80	3.30	3.49	1.92	3.73	3.73	3.32	1.30	2.96	5.10	6.13	6.42	5.93	4.40	2.88	-8.87
Income from Continuing Operations	–	–	–	–	5.85	14	14	13	8.84	4.79	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	–	–	0	0	1.57	19	1.17	-1.04	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	14	16	32	10	3.76	–	–	–	–	–	–	–
Net Income	18	20	15	12	5.85	14	16	32	10	3.76	8.62	10	8.42	7.65	6.94	4.15	14
EPS (Basic)(per share)	0.61	0.66	0.50	0.39	0.19	0.44	0.49	1.00	0.31	0.12	0.29	0.38	0.31	0.29	0.31	0.19	0.65
EPS (Diluted)(per share)	0.61	0.66	0.50	0.39	0.18	0.44	0.49	1.00	0.31	0.12	0.28	0.37	0.30	0.28	0.29	0.18	0.64
Shares Outstanding (Basic, Weighted)(shares)	30	30	31	31	32	32	32	32	32	32	30	28	27	26	22	22	0.02
Shares Outstanding (Diluted, Weighted)(shares)	30	31	31	31	32	32	32	32	32	32	30	28	28	28	24	22	0.02
Dividend per Share(per share)	0.12	0.11	0.10	0.00	0.00	–	–	1.00	–	–	–	–	–	–	–	–	–
EBITDA	64	63	57	50	45	46	43	40	33	28	31	27	23	20	17	12	10

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 65.1%
Operating margin: 8.0%
Net margin: 6.6%
Return on equity, FY2025: 5.1%

Financial strength

Current ratio: 1.06
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 37.6%

Valuation

P/E ratio: 46.3
Price to sales: 3.04
Price to book: 2.74
Dividend yield: 0.37%